AJ

Anuradha Jampana

Active Director Director DIN 00860062
DIN 00860062 First appointment May 2003 Primary industry General Business
Unlock full profile Investments · shareholding · contact details
Current companies 4 active board seats
Past companies 2 historical roles
Total affiliations 6 Since May 2003
Shareholding value •••• Premium profile

About Anuradha Jampana

Data last updated:

Anuradha Jampana has 23 years in corporate governance. Holds Director and Additional Director roles. Currently with 4 companies, including Jampana Farms Private Limited and Clavita Pharma Private Limited. Formerly with 2 companies, such as Sriam Labs Private Limited and Natsol Laboratories Private Limited. Engaged in General Business. Contributes to corporate operations. The 2 current companies with reported revenue have a combined latest revenue of ₹15.28 Cr; the largest is Clavita Pharma Private Limited at ₹7.76 Cr (FY 2025).

DIN 00860062
Primary Designation Director
First Appointment 21 May 2003
Oldest Company Age 23 yrs
Largest company Clavita Pharma Private Limited · ₹7.76 Cr (FY 2025)
Combined revenue ₹15.28 Cr across 2 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Clavita Pharma Private Limited U24230AP2014PTC093698
Additional Director26 Mar 20182014₹7.76 Cr (FY 2025)Active
Director21 May 20032003₹7.52 Cr (FY 2021)Active
Lifecare Veda Private Limited U24304TG2022PTC168822
Director24 Oct 20232022–Active
Jampana Farms Private Limited U05000AP2017PTC105126
Director09 Feb 20172017–Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Sriam Labs Private Limited U24239AP2002PTC121365
Director22 Aug 20032002₹77.88 Cr (FY 2026)Active
Natsol Laboratories Private Limited U24100AP2009PTC111540
Additional Director15 Jul 20162009₹1.6 Lakh (FY 2022)Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Jampana Farms Private Limited
Clavita Pharma Private Limited
Lifecare Laboratories Private Limited
Lifecare Veda Private Limited
Premium access

Shareholding and investment profile for Anuradha Jampana

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Anuradha Jampana

Anuradha Jampana has 23 years in corporate governance. Holds Director and Additional Director roles. Currently with 4 companies, including Jampana Farms Private Limited and Clavita Pharma Private Limited. Formerly with 2 companies, such as Sriam Labs Private Limited and Natsol Laboratories Private Limited. Engaged in General Business. Contributes to corporate operations. The 2 current companies with reported revenue have a combined latest revenue of ₹15.28 Cr; the largest is Clavita Pharma Private Limited at ₹7.76 Cr (FY 2025).

Anuradha Jampana is associated with 4 companies as Director and Additional Director, including Clavita Pharma Private Limited (₹7.76 Cr), Lifecare Laboratories Private Limited (₹7.52 Cr), Lifecare Veda Private Limited.

Anuradha Jampana has expertise in General Business.

Anuradha Jampana has 23 years in corporate governance.

By reported revenue, the largest current company of Anuradha Jampana is Clavita Pharma Private Limited, with revenue of ₹7.76 Cr (FY 2025).

The 2 current companies of Anuradha Jampana that report revenue have a combined latest revenue of ₹15.28 Cr.

Anuradha Jampana currently holds positions at 4 companies: Clavita Pharma Private Limited (₹7.76 Cr), Lifecare Laboratories Private Limited (₹7.52 Cr), Lifecare Veda Private Limited, Jampana Farms Private Limited.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available